Deutsche Bank
LJPC

Deutsche Bank’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Deutsche Bank’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-35
Closed – – 4553
2021
Q3 		$0 Sell
35
-55,960
-100% -$222K ﹤0.01% 4851
2021
Q2 		$239K Sell
55,995
-12,923
-19% -$55.4K ﹤0.01% 3684
2021
Q1 		$292K Sell
68,918
-1,093
-2% -$6.02K ﹤0.01% 3431
2020
Q4 		$272K Buy
70,011
+3,114
+5% +$13.3K ﹤0.01% 3292
2020
Q3 		$270K Buy
66,897
+11,212
+20% +$46.4K ﹤0.01% 3042
2020
Q2 		$237K Buy
55,685
+8,689
+18% +$52.9K ﹤0.01% 3053
2020
Q1 		$197K Buy
46,996
+26,561
+130% +$168K ﹤0.01% 2951
2019
Q4 		$80K Buy
20,435
+14,321
+234% +$84.6K ﹤0.01% 3693
2019
Q3 		$53K Buy
6,114
+107
+2% +$1.01K ﹤0.01% 3906
2019
Q2 		$54K Sell
6,007
-20,955
-78% -$158K ﹤0.01% 4485
2019
Q1 		$172K Sell
26,962
-20,841
-44% -$136K ﹤0.01% 4078
2018
Q4 		$450K Sell
47,803
-75,034
-61% -$1.13M ﹤0.01% 3416
2018
Q3 		$2.47M Buy
122,837
+79,083
+181% +$2.07M ﹤0.01% 2715
2018
Q2 		$1.28M Sell
43,754
-60,135
-58% -$1.86M ﹤0.01% 3262
2018
Q1 		$3.09M Buy
103,889
+64,571
+164% +$2.08M ﹤0.01% 2579
2017
Q4 		$1.26M Sell
39,318
-15,973
-29% -$522K ﹤0.01% 3037
2017
Q3 		$1.92M Sell
55,291
-23,316
-30% -$750K ﹤0.01% 2567
2017
Q2 		$2.34M Buy
78,607
+20,255
+35% +$580K ﹤0.01% 2455
2017
Q1 		$1.74M Buy
58,352
+20,219
+53% +$516K ﹤0.01% 2332
2016
Q4 		$666K Buy
38,133
+744
+2% +$14.3K ﹤0.01% 2981
2016
Q3 		$888K Buy
37,389
+4,062
+12% +$76.5K ﹤0.01% 2894
2016
Q2 		$533K Sell
33,327
-1,774
-5% -$31.8K ﹤0.01% 3252
2016
Q1 		$733K Sell
35,101
-102,701
-75% -$1.83M ﹤0.01% 2991
2015
Q4 		$3.72M Sell
137,802
-7,501
-5% -$205K ﹤0.01% 2006
2015
Q3 		$4.04M Buy
145,303
+94,427
+186% +$2.98M ﹤0.01% 1961
2015
Q2 		$1.25M Buy
50,876
+10,876
+27% +$224K ﹤0.01% 2826
2015
Q1 		$732K Buy
40,000
+10,000
+33% +$203K ﹤0.01% 3079
2014
Q4 		$553K Buy
+30,000
New +$356K ﹤0.01% 3608
2014
Q3 		– Sell
-1,500
Closed -$13K – 6470
2014
Q2 		$13K Buy
1,500
+900
+150% +$8.21K ﹤0.01% 5445
2014
Q1 		$6K Buy
+600
New +$5.89K ﹤0.01% 5167

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank's LJPC Position: Q4 2021 in Review

Deutsche Bank sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2021, closing a stake of 35 shares.

Deutsche Bank first reported a position in LJPC in Q1 2014 and held it in 30 quarters. The position peaked at $4.04M in Q3 2015. 44 funds tracked by Wall St. Rank hold LJPC as of Q4 2021.

  • Deutsche Bank reported no remaining La Jolla Pharmaceutical Company position as of Q4 2021 after selling out during the quarter.
  • Deutsche Bank sold 35 La Jolla Pharmaceutical Company shares in Q4 2021.
  • Deutsche Bank first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 30 quarters.
  • Deutsche Bank's La Jolla Pharmaceutical Company position peaked at $4.04M in Q3 2015.
  • 44 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2021.

Based on Deutsche Bank's 13F filing for Q4 2021, filed 11 Feb 2022.